A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium Health, Inc.
Ossium Health, Inc.
Pfizer
Seagen Inc.
Compass Therapeutics
GlaxoSmithKline
Bio-Path Holdings, Inc.
Takeda
Mundipharma Research Limited
Pfizer
Seagen Inc.
Atara Biotherapeutics
Seagen Inc.
MultiVir, Inc.
Celgene
Hoffmann-La Roche
Progen Pharmaceuticals
Morphotek
INSYS Therapeutics Inc
Novartis
Seagen Inc.